Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Other Non Operating Income (2016 - 2025)

Macrogenics (MGNX) has disclosed Other Non Operating Income for 14 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 31.16% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 million, a 35.7% decrease, with the full-year FY2025 number at $6.1 million, down 35.71% from a year prior.
  • Other Non Operating Income was $1.4 million for Q4 2025 at Macrogenics, down from $1.5 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.3 million in Q4 2023 to a low of $21000.0 in Q1 2021.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2025 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: crashed 97.09% in 2021, then soared 2052.11% in 2023.
  • Macrogenics' Other Non Operating Income stood at $214000.0 in 2021, then surged by 282.71% to $819000.0 in 2022, then soared by 300.73% to $3.3 million in 2023, then plummeted by 36.44% to $2.1 million in 2024, then tumbled by 31.16% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Other Non Operating Income are $1.4 million (Q4 2025), $1.5 million (Q3 2025), and $1.4 million (Q2 2025).